Cargando…
Lactotransferrin Downregulation Serves as a Potential Predictor for the Therapeutic Effectiveness of mTOR Inhibitors in the Metastatic Clear Cell Renal Cell Carcinoma without PTEN Mutation
Approximately 30% of clear cell renal cell carcinoma (ccRCC) patients develop metastatic spread at the first diagnosis. Therefore, identifying a useful biomarker to predict ccRCC metastasis or therapeutic effectiveness in ccRCC patients is urgently needed. Previously, we demonstrated that lactotrans...
Autores principales: | Zheng, Jing-Quan, Lin, Che-Hsuan, Lee, Hsun-Hua, Wang, Wen-Ke, Tong, Yiu-Shun, Lee, Kang-Yun, Chiu, Hui-Wen, Lin, Yuan-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698394/ https://www.ncbi.nlm.nih.gov/pubmed/34944711 http://dx.doi.org/10.3390/biomedicines9121896 |
Ejemplares similares
-
Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020) -
Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer
por: Luo, Gengqiu, et al.
Publicado: (2021) -
Analysis of Polymorphisms in the Lactotransferrin Gene Promoter and Dental Caries
por: Brancher, João Armando, et al.
Publicado: (2011) -
Novel lactotransferrin-derived synthetic peptides suppress cariogenic bacteria in vitro and arrest dental caries in vivo: [Novel lactotransferrin-derived anticaries peptides]
por: Luo, Junyuan, et al.
Publicado: (2021) -
C-Reactive Protein Inhibits Survivin Expression via Akt/mTOR Pathway Downregulation by PTEN Expression in Cardiac Myocytes
por: Lee, Beom Seob, et al.
Publicado: (2014)